| 1. |
- Cecchinato, Francesca, et al.
(författare)
-
Osteogenic potential of human adipose-derived stromal cells on 3-dimensional mesoporous TiO2 coating with magnesium impregnation
- 2015
-
Ingår i: Materials Science and Engineering C. - : Elsevier BV. - 0928-4931 .- 1873-0191. ; 52, s. 225-234
-
Tidskriftsartikel (refereegranskat)abstract
- The aim of this study was to evaluate the osteogenic response of human adipose-derived stromal cells (ADScs) to mesoporous titania (TiO2) coatings produced with evaporation-induced self-assembly method (EISA) and loaded with magnesium. Our emphasis with the magnesium release functionality was to modulate progenitor cell osteogenic differentiation under standard culture conditions. Osteogenic properties of the coatings were assessed for stromal cells by means of scanning electron microscopy (SEM) imaging, colorimetric mitochondrial viability assay (MTT), colorimetric alkaline phosphates activity (ALP) assay and real time RT-polymerase chain reaction (PCR). Using atomic force microscopy (AFM) it was shown that the surface expansion area (S-dr) was strongly enhanced by the presence of magnesium. From MTT results it was shown that ADSc viability was significantly increased on mesoporous surfaces compared to the non-porous one at a longer cell culture time. However, no differences were observed between the magnesium impregnated and non-impregnated surfaces. The alkaline phosphatase activity confirmed that ADSc started to differentiate into the osteogenic phenotype after 2 weeks of culturing. The gene expression profile at 2 weeks of cell growth showed that such coatings were capable to incorporate specific osteogenic markers inside their interconnected nano-pores and, at 3 weeks, ADSc differentiated into osteoblasts. Interestingly, magnesium significantly promoted the osteopontin gene expression, which is an essential gene for the early biomaterial-cell osteogenic interaction. (C) 2015 Elsevier B.V. All rights reserved.
|
|
| 2. |
- Folkesson, Peter, 1968, et al.
(författare)
-
Back-to-Back Fault Injection Testing in Model-Based Development
- 2015
-
Ingår i: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). - Cham : Springer International Publishing. - 1611-3349 .- 0302-9743. - 9783319242545 - 9783319242552 ; 9337, s. 135-148
-
Konferensbidrag (refereegranskat)abstract
- Today, embedded systems across industrial domains (e.g., avionics, automotive) are representatives of software-intensive systems with increasing reliance on software and growing complexity. It has become critically important to verify software in a time, resource and cost effective manner. Furthermore, industrial domains are striving to comply with the requirements of relevant safety standards. This paper proposes a novel workflow along with tool support to evaluate robustness of software in model-based development environment, assuming different abstraction levels of representing software. We then show the effectiveness of our technique, on a brake-by-wire application, by performing back-to-back fault injection testing between two different abstraction levels using MODIFI for the Simulink model and GOOFI-2 for the generated code running on the target microcontroller. Our proposed method and tool support facilitates not only verifying software during early phases of the development lifecycle but also fulfilling back-to-back testing requirements of ISO 26262 when using model-based development.
|
|
| 3. |
- Karlsson, Johan, 1984, et al.
(författare)
-
Ex vivo alendronate localization at the mesoporous titania implant/bone interface
- 2015
-
Ingår i: Journal of materials science. Materials in medicine. - : Springer Science and Business Media LLC. - 1573-4838 .- 0957-4530. ; 26
-
Tidskriftsartikel (refereegranskat)abstract
- An attractive approach in implant technology is local drug delivery, and design of efficient, safe and reliable treatments. Ourhitherto strategy has been to coat Ti implants with a thin mesoporous TiO2 film that in turnis loaded with an osteoporosis drug, such as Alendronate (ALN) that is known to suppress osteoclastic activity. This system has proven highly successful and results in excellent osseointegration. However, more detailed information about drug-release and distribution at the bone/implant interface is needed. In this study, (14)C-ALN loaded titanium implants were placed up to 8weeks into rat tibia and the spatial-temporal distribution of the drug was evaluated. Autoradiography data demonstrated a sustained release of (14)C-ALN and the releaseddrug remained bound to bone in close vicinity, within 500 micrometers,of the implants. Liquid scintillation counting experiments confirmed that the distal transport of released (14)C-ALN was extremely low. The results are favorable as they show that ALN stays for a long time in the vicinity of the implant and may therefore improve for a long time the mechanical fixation of bone anchored implants. Moreover, these findings suggest due to the low systemic spreading a minimal risk of Alendronate related systemic side effects.
|
|
